Sagimet closes $115 million stock offering for drug development

🌐 Investing.com (Cyprus) — 2026-10-01

Sagimet completed a $115 million stock offering to fund its drug development work. The report provides no further details on the offering structure or specific development programs.

Markets Health Sagimet stock offering equity financing drug development biotechnology

Read original source →

Tung Chee-hwa’s task as Hong Kong’s chief executive was without precedent
South China Morning Post — 2026-10-01
TinOne Resources closes $750,000 private placement financing
Investing.com — 2026-10-01
Fomento Económico: Quench Your Thirst For Value With The Largest Bottler Of Coca-Cola
Seeking Alpha — 2026-10-01
STAT+: Medicare Advantage plans shift more costs onto seniors in 2027
STAT News Health — 2026-10-01
Wabash National: The Stock Already Prices In Expensive Trailer Market Dynamics
Seeking Alpha — 2026-10-01
Fortress Biotech repays $15 million Oaktree credit facility in full
Investing.com — 2026-10-01

Sagimet closes $115 million stock offering for drug development

AI Summary

Related Articles

Tung Chee-hwa’s task as Hong Kong’s chief executive was without precedent

TinOne Resources closes $750,000 private placement financing

Fomento Económico: Quench Your Thirst For Value With The Largest Bottler Of Coca-Cola

STAT+: Medicare Advantage plans shift more costs onto seniors in 2027

Wabash National: The Stock Already Prices In Expensive Trailer Market Dynamics

Fortress Biotech repays $15 million Oaktree credit facility in full